摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲氧基-6-三氟甲基吡啶 | 34486-18-5

中文名称
2-甲氧基-6-三氟甲基吡啶
中文别名
2-甲氧基-6-(三氟甲基)吡啶
英文名称
2-methoxy-6-(trifluoromethyl)pyridine
英文别名
——
2-甲氧基-6-三氟甲基吡啶化学式
CAS
34486-18-5
化学式
C7H6F3NO
mdl
MFCD12026108
分子量
177.126
InChiKey
VBEYJZVICNLLDA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    149.8±40.0 °C(Predicted)
  • 密度:
    1.263±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.285
  • 拓扑面积:
    22.1
  • 氢给体数:
    0
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2933399090
  • 危险性防范说明:
    P233,P260,P261,P264,P270,P271,P280,P301+P312,P302+P352,P304,P304+P340,P305+P351+P338,P312,P321,P330,P332+P313,P337+P313,P340,P362,P403,P403+P233,P405,P501
  • 危险性描述:
    H302,H315,H319,H332,H335

SDS

SDS:7afaf68c6b2bdd92186f1c5f3eded5d1
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Methoxy-6-(trifluoromethyl)pyridine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Methoxy-6-(trifluoromethyl)pyridine
CAS number: 34486-18-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H6F3NO
Molecular weight: 177.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-甲氧基-6-三氟甲基吡啶正丁基锂 、 XPhos Pd G2 、 caesium carbonate 作用下, 以 四氢呋喃1,4-二氧六环 为溶剂, 生成 1-(5-chloro-4-fluoro-2-hydroxy-3-(2-methoxy-6-(trifluoromethyl)pyridin-3-yl)phenyl)ethan-1-one
    参考文献:
    名称:
    [EN] IMIDAZO [1,5-A] PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORS
    [FR] DÉRIVÉS D'IMIDAZO [1,5-A] PYRAZINE EN TANT QU'INHIBITEURS DE PI3KDELTA
    摘要:
    揭示的是化合物的化学式(I),或其立体异构体,或其药学上可接受的盐,以及包含其的药物组合物。还公开了利用此处披露的化合物治疗PI3Kδ相关疾病或疾病的方法。
    公开号:
    WO2018103688A1
  • 作为产物:
    描述:
    2-氟-6-(三氟甲基)吡啶 、 silver carbonate 、 potassium hydroxide 作用下, 以 二氯甲烷 为溶剂, 反应 24.0h, 生成 2-甲氧基-6-三氟甲基吡啶
    参考文献:
    名称:
    [EN] IMIDAZO [1,5-A] PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORS
    [FR] DÉRIVÉS D'IMIDAZO [1,5-A] PYRAZINE EN TANT QU'INHIBITEURS DE PI3KDELTA
    摘要:
    揭示的是化合物的化学式(I),或其立体异构体,或其药学上可接受的盐,以及包含其的药物组合物。还公开了利用此处披露的化合物治疗PI3Kδ相关疾病或疾病的方法。
    公开号:
    WO2018103688A1
点击查看最新优质反应信息

文献信息

  • 8-AZABICYCLO[3.2.1]OCTANE-8-CARBOXAMIDE DERIVATIVE
    申请人:Horiuchi Yoshihiro
    公开号:US20120225876A1
    公开(公告)日:2012-09-06
    Disclosed is a compound represented by formula (1) or a pharmacologically acceptable salt thereof (In the formula, A represents a group that is represented by formula (A-1); R 1a and R 1b may be the same or different and each independently represents a C 1-6 alkyl group which may be substituted by one to three halogen atoms; m and n each independently represents an integer of 0-5; X 1 represents a hydroxyl group or an aminocarbonyl group; Z 1 represents a single bond or the like; and R 2 represents an optionally substituted C 1-6 alkyl group, an optionally substituted C 6-10 aryl group or the like.)
    公开了一种由公式(1)表示的化合物或其药理可接受的盐(在公式中,A代表由公式(A-1)表示的基团;R1a和R1b可以相同或不同,每个独立地表示一个可以由一个到三个卤素原子取代的C1-6烷基;m和n各自独立地表示0-5之间的整数;X1代表羟基或氨基甲酰基;Z1代表单键等;R2代表一个可选地取代的C1-6烷基,一个可选地取代的C6-10芳基等)。
  • COMPOUNDS USEFUL AGAINST KINETOPLASTIDEAE PARASITES
    申请人:Davioud-Charvet Elisabeth
    公开号:US20120214996A1
    公开(公告)日:2012-08-23
    Dibenzylidene and heterobenzylideneacetone derivatives, related 4-piperidones, related 4-thiopyranones and the corresponding sulfinyl- and sulfonyl-analogues for their use for prophylaxis or treatment of trypanosomiasis and leishmaniasis.
    二苄基亚烷和杂二苄基亚烷乙酮衍生物,相关的4-哌啶酮,相关的4-噻opyranones以及相应的亚磺酰基和磺酰基类似物,用于预防或治疗锥虫病和利什曼病。
  • [EN] HERBICIDAL PYRIDAZINONE DERIVATIVES<br/>[FR] DÉRIVÉS HERBICIDES DE PYRIDAZINONE
    申请人:SYNGENTA LTD
    公开号:WO2013050421A1
    公开(公告)日:2013-04-11
    The present invention provides a compound of Formula (I) or an agronomically acceptable salt thereof, wherein:R2 is selected from the group consisting of (A1), (A2) and (A3) wherein X1 is N or CR7 X2 is N or CR8 X3 is N or CR9 X4 is N or CR6 R1, R3, R4, R5 R6, R7, R8 and R9 are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I), and to their use for controlling weeds, in particular in crops of useful plants.
    本发明提供了一种式(I)的化合物或其农业上可接受的盐,其中:R2选自由(A1)、(A2)和(A3)组成的群,其中X1为N或CR7,X2为N或CR8,X3为N或CR9,X4为N或CR6,R1、R3、R4、R5、R6、R7、R8和R9如本文所定义。该发明还涉及包括式(I)的化合物的除草剂组合物,以及它们在控制杂草方面的用途,特别是在有用植物作物中。
  • HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD CONTROLLING AGENT CONTAINING SAME
    申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
    公开号:US20210084903A1
    公开(公告)日:2021-03-25
    The present invention provides a compound substituted with an excellent control effect against a harmful arthropod, which is represented by formula (I) Het-Q  (I) wherein Q represents a group represented by Q1, etc., Het represents a group represented by Het1, etc., R 2 represents a C1-C6 alkyl group, etc., G 1 represents a nitrogen atom or CR 3a , G 2 represents a nitrogen atom or CR 3b , G 3 represents a nitrogen atom or CR 3c , G 4 represents a nitrogen atom or CR 3d , R 3a , R 3b , R 3c , and R 3d are identical to or different from each other and represent a C1-C6 chain hydrocarbon group, etc., n represents 0, 1, or 2, T represents a C1-C10 chain hydrocarbon group substituted with one or more halogen atoms, etc., A 2 represents a nitrogen atom or CR 4a , A 3 represents a nitrogen atom or CR 4b , R 4a and R 4b are identical to or different from each other and represent a C1-C6 chain hydrocarbon group, W 1 represents an oxygen atom, etc., and R 6 represents a C1-C6 chain hydrocarbon group, etc.
    本发明提供了一种具有对有害节肢动物具有优异控制效果的化合物,其表示为公式(I)Het-Q(I),其中Q代表由Q1等表示的基团,Het代表由Het1等表示的基团,R2代表C1-C6烷基基团等,G1代表氮原子或CR3a,G2代表氮原子或CR3b,G3代表氮原子或CR3c,G4代表氮原子或CR3d,R3a、R3b、R3c和R3d彼此相同或不同且代表C1-C6链烃基团等,n代表0、1或2,T代表一个或多个卤原子取代的C1-C10链烃基团等,A2代表氮原子或CR4a,A3代表氮原子或CR4b,R4a和R4b彼此相同或不同且代表C1-C6链烃基团,W1代表氧原子等,R6代表C1-C6链烃基团等。
  • RORGamma Modulators
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:US20150266856A1
    公开(公告)日:2015-09-24
    Described are RORy modulators of the formula (I), and N-oxides thereof, and pharmaceutically acceptable salts thereof, and solvates and hydrates thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R a , x, y, L, G, Z, the bond denoted by “q”, the ring system denoted by “A” and the ring system denoted by “B” are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for modulating RORy activity in a cell and methods for treating a subject suffering from a disease or disorder in which the subject would therapeutically benefit from modulation of RORy activity, for example, autoimmune and/or inflammatory disorders.
    本文描述了公式(I)的RORy调节剂及其N-氧化物、药学上可接受的盐、溶剂和水合物,其中R1、R2、R3、R4、R5、R6、Ra、x、y、L、G、Z、“q”表示的键、表示的环系统“A”和表示的环系统“B”在此定义。还提供了包含这些化合物的制药组合物。这些化合物和组合物在调节细胞中的RORy活性的方法和治疗患有疾病或障碍的受试者中是有用的,其中该受试者在调节RORy活性方面具有治疗益处,例如自身免疫和/或炎症性疾病。
查看更多